Synonyms |
|
ALP |
Part of
Profile |
|
Liver Function
Test, Bone.
|
Clinical
Indications |
|
ALP
rises in the presence of bile duct obstruction (e.g. primary
biliary cirrhosis, gallstones, bile duct strictures).
ALP is also elevated in bone disease where increased
osteoblastic activity is involved (e.g. malignancy (not
myeloma), osteomalcia, pagets)
|
Request Form |
|
Combined Pathology Blood form
(Yellow/Black)
|
Availability |
|
On
request
|
Turnaround
Time |
|
Same
day.
|
Specimen |
|
Serum
|
Volume |
|
2 ml
|
Container |
|
Yellow top (SST) tube
|
Collection |
|
No specific collection
conditions
|
Causes for
Rejection |
|
Unlabelled
specimen
|
Reference
range |
|
Adult: 30 - 130
IU/L. Mild increases in ALP may be seen as a result of
age-related changes, particularly in older women.
Children: 30 - 350 IU/L. Levels is children may be mildly elevated during
growth spurts. |
Interpretation |
|
Elevated
ALP may be as a result of liver or bone disease. Certain
medications may also cause rises in ALP. A normal gamma-GT may
be used to exclude liver disease, but a raised gamma-GT does
not exclude bone disease (since liver and bone disease may
both be present).
In bone disease, particularly high levels of ALP are
seen in Paget's disease. It should be noted that rises in ALP
are not seen in osteoporosis or myeloma as increased
osteoblastic activity is not involved.
High levels of ALP may be due to transient
hyperphosphatasaemia of childhood, which can occur in younger
adults. Alkaline phosphatase
isoenzyme analysis is indicated.
|
Critical Difference |
|
22 IU/L
|